Badino R, Trucco M, Caja A, Del Conte I, Guida C, Ivaldi M
Ital J Neurol Sci. 1994; 15(4):183-7.
PMID: 7960671
DOI: 10.1007/BF02339321.
Moriuchi K, Imazu Y, Yoneda H
Neurochem Res. 1995; 20(1):95-9.
PMID: 7739765
DOI: 10.1007/BF00995158.
Carey R, Thorner M, Ortt E
J Clin Invest. 1980; 66(1):10-8.
PMID: 7400305
PMC: 371499.
DOI: 10.1172/JCI109822.
Kohler C, Haglund L, Ogren S, Angeby T
J Neural Transm. 1981; 52(3):163-73.
PMID: 7198139
DOI: 10.1007/BF01249601.
Hyttel J
Psychopharmacology (Berl). 1980; 67(1):107-9.
PMID: 6768074
DOI: 10.1007/BF00427604.
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
Rupniak N, Mann S, Hall M, Fleminger S, Kilpatrick G, Jenner P
Psychopharmacology (Berl). 1984; 84(4):503-11.
PMID: 6441951
DOI: 10.1007/BF00431457.
Effects of chronic sultopride treatment on endocrine systems in psychotic women.
Miyachi Y, Mizuchi A, Hamano H, Sarai K
Psychopharmacology (Berl). 1984; 82(4):287-90.
PMID: 6427815
DOI: 10.1007/BF00427671.
Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay.
Mizuchi A, Kitagawa N, Miyachi Y
Psychopharmacology (Berl). 1983; 81(3):195-8.
PMID: 6417707
DOI: 10.1007/BF00427261.
Involvement of dopaminergic neurotransmission in the control of goal-directed movements.
Schmidt W
Psychopharmacology (Berl). 1983; 80(4):360-4.
PMID: 6312482
DOI: 10.1007/BF00432121.
Brain locations controlling the behavioral effects of chronic amphetamine intoxication.
Hitzemann R, Wu J, Hom D, Loh H
Psychopharmacology (Berl). 1980; 72(1):93-101.
PMID: 6162168
DOI: 10.1007/BF00433812.
Effects of tiapride on homovanillic acid levels in human cerebrospinal fluid drawn at pneumoencephalography.
Spissu A, Congia S, Piccardi M, Fadda F, Mangoni A, Gessa G
Psychopharmacology (Berl). 1980; 71(1):7-9.
PMID: 6161384
DOI: 10.1007/BF00433245.
Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models.
Stanley M, Lautin A, Rotrosen J, Gershon S, Kleinberg D
Psychopharmacology (Berl). 1980; 71(3):219-25.
PMID: 6109348
DOI: 10.1007/BF00433055.
A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine.
Davis A, Jenner P, Marsden C
Br J Pharmacol. 1986; 87(1):129-37.
PMID: 3955297
PMC: 1916888.
DOI: 10.1111/j.1476-5381.1986.tb10164.x.
BRL 20596, a novel anilide with central dopamine antagonist activity.
Campbell W, Clark M, Mitchell P, Needham P, Semple J
Psychopharmacology (Berl). 1986; 89(2):208-15.
PMID: 3088638
DOI: 10.1007/BF00310631.
Single oral dose pharmacokinetics of tiapride in patients with Huntington's disease.
Norman T, Chiu E, James R, Gregory M
Eur J Clin Pharmacol. 1987; 32(6):583-6.
PMID: 2958291
DOI: 10.1007/BF02455992.
[3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.
Grigoriadis D, Seeman P
Naunyn Schmiedebergs Arch Pharmacol. 1986; 332(1):21-5.
PMID: 2869417
DOI: 10.1007/BF00633192.
Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
Niznik H, Grigoriadis D, Buchman O, Seeman P
Naunyn Schmiedebergs Arch Pharmacol. 1985; 329(4):333-43.
PMID: 2863760
DOI: 10.1007/BF00496365.
Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists.
Muscat R, Montgomery A, Willner P
Psychopharmacology (Berl). 1989; 99(3):402-8.
PMID: 2531902
DOI: 10.1007/BF00445567.
Effects of dopamine receptor antagonists on sucrose consumption and preference.
Muscat R, Willner P
Psychopharmacology (Berl). 1989; 99(1):98-102.
PMID: 2506610
DOI: 10.1007/BF00634461.
A matching law analysis of the effects of dopamine receptor antagonists.
Willner P, Sampson D, Phillips G, Muscat R
Psychopharmacology (Berl). 1990; 101(4):560-7.
PMID: 2201990
DOI: 10.1007/BF02244238.
